Si Taili: Completion of the sale of 9.8672% equity stake in the joint venture company.

Sita Li announced that the company approved the sale of equity in a joint venture company on August 28, 2025, intending to transfer 9.8672% of the equity of Yunuo Medicine to Fosun Pharma for 66.4416 million yuan. As all the conditions for delivery agreed upon in the contract were met, both parties recently completed the business registration procedures for the transfer of equity. The company has received the full amount of the transfer payment, and the equity transfer has been completed.